LP-098 Proteomic analysis of histological lesions in lupus nephritis identifies an inflammatory signature of fibrous crescents by Laurence S Magder, Michelle Petri, Jill Buyon, Peter Izmirly, Betty Diamond, Paride Fenaroli, Daniel W Goldman, ANNE DAVIDSON, Andrea Fava, Judith James, Michael Belmont, Jose Monroy-Trujillo, Mohamed G Atta, William Apruzzese, Jeffrey Hodgin, Derek Fine, Alessandra Ida Celia, Dwita Demeke, Avi Rosenberg

1112 Change in urinary biomarkers at three months predicts 1-year treatment response of lupus nephritisbetter than proteinuria by Judith A James, Maria Dall’Era, Jill Buyon, Peter Izmirly, Betty Diamond, Soumya Raychaudhuri, Nir Hacohen, Daniel W Goldman, H Michael Belmont, Laurence Magder, ANNE DAVIDSON, Deepak Rao, Andrea Fava, Arnon Arazi, Mohamed G Atta, William Apruzzese, Derek Fine, Joel Guthdridge, Jose Monroy Trujillo

1702 Patients enrolled in the accelerating medicines partnership (AMP) RA/SLE network with isolated renal disease report minimal quality of life impairment on PROMIS-29 compared to... by Richard Furie, Michelle Petri, Judith A James, Kenneth Kalunian, Maria Dall’Era, Jill Buyon, Chaim Putterman, Peter Izmirly, Betty Diamond, Jessica Li, Jennifer Anolik, H Michael Belmont, Philip Carlucci, Deepak Rao, Andrea Fava, Diane Kamen, Celine Berthier, Jose Monroy-Trujillo, Kristin Haag, William Apruzzese, Sean Connery, Fernanda Payan-Schober, Kerry Cho, Kristina Deonaraine, Derek Fine, Heather T Gold, Susana Serrate-Sztein

Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network by Peter M. Izmirly, Mimi Y. Kim, Philip M. Carlucci, Katherine Preisinger, Brooke Z. Cohen, Kristina Deonaraine, Devyn Zaminski, Maria Dall’Era, Kenneth Kalunian, Andrea Fava, H. Michael Belmont, Ming Wu, Chaim Putterman, Jennifer Anolik, Jennifer L. Barnas, Betty Diamond, Anne Davidson, David Wofsy, Diane Kamen, Judith A. James, Joel M. Guthridge, William Apruzzese, Deepak A. Rao, Michael H. Weisman, The Accelerating Medicines Partnership in RA/SLE Network, Michelle Petri, Jill Buyon, Richard Furie

Get full text

LO-006 Change in urinary biomarkers at three months predicts 1-year treatment response of lupus nephritis better than proteinuria by Richard Furie, Michelle Petri, Judith A James, Kenneth Kalunian, Maria Dall’Era, Jill Buyon, Chaim Putterman, Peter Izmirly, Betty Diamond, David Wofsy, Soumya Raychaudhuri, Daniel Goldman, Nir Hacohen, Jennifer Anolik, H Michael Belmont, Laurence Magder, Robert Clancy, ANNE DAVIDSON, Deepak Rao, Andrea Fava, Diane Kamen, Joel Guthridge, Celine Berthier, Arnon Arazi, Jose Monroy-Trujillo, Mohamed G Atta, William Apruzzese, Jennifer Barnas, Paul Hoover, Jeffrey Hodgin, Derek Fine, Alessandra Ida Celia, Avi Rosenberg, Dawit Demeke

1107 Immune cell heterogeneity in lupus nephritis kidneys and its relation to histopathological features: lessons from the accelerating medicines partnership (AMP) in SLE Consortiu... by Richard Furie, Joel M Guthridge, Judith A James, Maria Dall’Era, Michelle A Petri, Chaim Putterman, Jill P Buyon, Diane L Kamen, Betty Diamond, David Wofsy, Soumya Raychaudhuri, Thomas Tuschl, Jennifer Grossman, Peter M Izmirly, Qian Xiao, Nir Hacohen, Kenneth C Kalunian, Michael B Brenner, Mariko Ishimori, H Michael Belmont, Robert Clancy, ANNE DAVIDSON, Matthias Kretzler, Michael Weisman, Celine C Berthier, Andrea Fava, Jennifer L Barnas, Jennifer H Anolik, Paul J Hoover, Deepak A Rao, Arnon Arazi, William Apruzzese, Fernanda Payan-Schober, Saori Sakaue, James Lederer, Michael Peters, Tony Jones, Jospeh Mears, Thomas M Eisenhaure, Siddarth Gurajala, Derek Fine, David A Hildeman, Steve Woodle, Maureen A McMahon, Jeffery Hodgin